Azelastine Hydrochloride
- Product NDC
- 42291-094
- 11-digit product format
- 422910094
- Labeler code
- 42291
- Product ID
- 42291-094_485b8c18-0782-37ea-e063-6394a90ad61e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Azelastine
- Dosage form
- SPRAY, METERED
- Route
- NASAL
- Labeler
- AvKARE
- Application
- ANDA204660
- Marketing category
- ANDA
- Marketing start
- 2021-03-03
- Substance
- AZELASTINE HYDROCHLORIDE
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Azelastine Hydrochloride
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| AZELASTINE HYDROCHLORIDE | 1 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 0L591QR10I |
| Rxcui | 1797867 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 42291-094-30 | Azelastine Hydrochloride | 1 in 1 CARTON | SPRAY, METERED | 1 | | 4 |
| 42291-094-30 | Azelastine Hydrochloride | 30 mL in 1 BOTTLE, SPRAY | SPRAY, METERED | 30 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42291-094 | AZELASTINE HYDROCHLORIDE (AZELASTINE) SPRAY, METERED [AVKARE] | 3 | Current NDC, Legacy NDC, 2 package rows | 20240110_bca75501-4140-4d77-e053-2a95a90a019f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-094-30 | 42291009430 | 1 BOTTLE, SPRAY in 1 CARTON (42291-094-30) / 30 mL in 1 BOTTLE, SPRAY | 2021-03-03 | 0000-00-00 | No | No | Current |